Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
MORC3 (KIAA0136/ZCWCC3/NXP2) was originally identified through a sequencing program designed to understand the structural information of unidentified human genes. The functional map of MORC3 reveals that MORC3 is a nuclear matrix protein that contains a putative RNA binding site in its nuclear matrix binding domain, which is critical for transcriptional regulation. MORC3 is ubiquitously expressed and has a high level of expression in immune cells.
MORC3 Related Regulation
In addition, MORC3 expression was up-regulated in normal peripheral leukocytes after chemotherapy, suggesting that in response to chemotherapy-induced cell damage. MORC3 and other differentially expressed genes may collectively regulate cell survival and apoptosis. It has been reported that MORC3 activates p53 and localizes it in the nucleus of promyelocytic leukemia (PML), thus playing an important role in p53-induced cellular senescence. MORC3 binds to PML proteins via the SUMO and SUMO interaction motifs (SIM). The CW-type zinc finger domain of MORC3 contains an important histone recognition motif specifically for H3K4 methylation and is required for proper localization of MORC3 in the nucleus. In addition, it has been reported that mouse MORC3 can localize to a promoter with H3K4me3 modification in the genome, which is consistent with the ability of MORC3 to bind H3K4me3 in vitro. These evidences suggest that MORC3 plays an important role in DNA damage repair and epigenetic regulation.
Figure 1. Multivalent Chromatin Engagement and Inter-domain Crosstalk Regulate MORC3 ATPase. (Andrews., et al. 2016)
Studies using the Down's syndrome mouse model (Ts65Dn and Ms5Yah) have shown that abnormal regulation of the MORC3 gene is associated with perinatal mortality and growth retardation. Another gene expression profiling of the brain in the Down's syndrome mouse model (Ts1Cje) showed that MORC3 is one of the differentially expressed genes in hippocampus. Functional clustering analysis of MORC3 and other differentially expressed genes revealed that the most prominent signaling pathway in the development of brain after Ts1Cje birth is the interferon-associated JAK-STAT signaling pathway. Other studies have shown that MORC3 interacts with the tyrosine kinase membrane receptor ROR1. ROR1 promotes the survival of acute lymphoblastic leukemia cells by activating downstream signaling pathways such as Akt and MAPK in concert with pre-B cell receptors. The above evidence indicates that MORC3 is involved in cell survival and proliferation-related signaling pathways such as JAK-STAT, Akt and MAPK.
MORC3 and Disease
MORC3 has been identified as an antigen for autoantibodies in approximately 25% of juvenile dermatomyositis (JDM) patients, a form of autoimmune barrier associated with skin calcium deposition. In 2018, Aouizerate et al. found significant myocardial ischemia and the presence of MORC3 (NXP2) autoantibodies in a severe JDM subtype. These anti-MORC3 autoantibodies were also detected in a subpopulation of adult dermatomyositis (ADM) patients. ADM-positive anti-MORC3 autoantibodies have been found in patients with a deciduous pemphigus (an autoimmune blistering disease, ABD). This antibody is present in several other autoimmune disorders, such as lupus erythematosus, rheumatoid arthritis, and systemic lupus erythematosus. Anti-MORC3 autoantibodies were detected in ADM patients with increased risk of cancer, suggesting that anti-MORC3 autoantibodies and other antibodies detected in ADM and autoimmune diseases may be associated with malignancies. In addition, calcifications in JDM patients are associated with increased expression of osteogenic markers, including osteocalcin (OCN), bone salivary protein (BSP), and stromal gla protein (MGP). These evidences suggest that MORC3 is involved in the regulation of calcium homeostasis that plays a key role in bone remodeling.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.